Patents by Inventor Jean-Marie Rakic

Jean-Marie Rakic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Eye device
    Patent number: 9999595
    Abstract: The invention provides a sustained release intraocular drug delivery device comprising: (a) a polymeric matrix core into which at least one therapeutic agent is mixed, and; (b) a polymeric coating completely surrounding said polymeric matrix material; wherein said polymeric matrix core and polymeric coating are insoluble and inert in ocular fluids, and wherein said sustained release intraocular drug delivery device has a compliant annular segment shape and is to be inserted into the sulcus of the intact and/or pseudophakic eye.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: June 19, 2018
    Assignee: EYED PHARMA
    Inventors: Jean-Marie Rakic, Jean-Michel Foidart
  • EYE DEVICE
    Publication number: 20160287513
    Abstract: The invention provides a sustained release intraocular drug delivery device comprising: (a) a polymeric matrix core into which at least one therapeutic agent is mixed, and; (b) a polymeric coating completely surrounding said polymeric matrix material; wherein said polymeric matrix core and polymeric coating are insoluble and inert in ocular fluids, and wherein said sustained release intraocular drug delivery device has a compliant annular segment shape and is to be inserted into the sulcus of the intact and/or pseudophakic eye.
    Type: Application
    Filed: November 14, 2014
    Publication date: October 6, 2016
    Applicant: Eyed Pharma
    Inventors: Jean-Marie Rakic, Jean-Michel Foidart
  • Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis
    Patent number: 8034828
    Abstract: The present invention thus relates to the use of 1,2,3-substituted indolizine derivatives in the preparation of medicaments of use in the treatment of diseases related to pathological choroidal angiogenesis, which derivatives correspond to the following general formula (I):
    Type: Grant
    Filed: August 29, 2008
    Date of Patent: October 11, 2011
    Assignee: Sanofi-Aventis
    Inventors: Alain Badorc, Francoise Bono, Marie-Francoise Bordes, Jean-Michel Foidart, Nathalie Guillo, Agnes Noel, Jean-Marie Rakic
  • USE OF FGF INHIBITING SUBSTITUTED 1,2,3 INDOLIZINE DERIVATIVES IN THE PREPARATION OF MEDICAMENTS WHICH CAN BE USED TO TREAT DISEASES LINKED TO PATHOLOGICAL CHOROIDAL ANGIOGENESIS
    Publication number: 20090030034
    Abstract: The present invention thus relates to the use of 1,2,3-substituted indolizine derivatives in the preparation of medicaments of use in the treatment of diseases related to pathological choroidal angiogenesis, which derivatives correspond to the following general formula (I):
    Type: Application
    Filed: August 29, 2008
    Publication date: January 29, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Alain BADORC, Francoise BONO, Marie-Francoise BORDES, Jean-Michel FOIDART, Nathalie GUILLO, Agnes NOEL, Jean Marie RAKIC